Summary: MAPS Founder and Executive Director Rick Doblin, Ph.D., joins Liam McClintock on The FitMind Podcast to discuss MAPS’ current efforts in the realm of psychedelic-assisted therapy. Doblin also discusses the wider field of psychedelic research, explaining that “in this moment in time, there are vastly more psychedelic scientific papers published than in the peak of the 1960s and early 1970s, so we are really in a renaissance of psychedelic research.”
Originally appearing here.
Dr. Rick Doblin is the Founder and Director of MAPS, which has raised over $100 million for supporting psychedelics research.
Rick is one of the key leaders of this current psychedelic renaissance, starting MAPS in 1986 with an aim toward making MDMA an FDA-approved medicine. With recent changes in public policy and a growing body of scientific research, he is close to making this dream a reality. Rick received a doctorate in public policy from Harvard’s Kennedy School of Government.
Topics include Stan Grof’s theories of the mind, psychedelic-assisted psychotherapy, and the journey towards the legalization of psychedelics.